Concepedia

Publication | Open Access

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

46

Citations

21

References

2017

Year

Abstract

In this prospective phase II study, pazopanib demonstrated promising activity and tolerable safety profile in patients with metastatic nccRCC.

References

YearCitations

Page 1